Giemsa Stain Kit (ab150670)
Key features and details
- Sample type: Tissue sections
Overview
-
Product name
Giemsa Stain Kit -
Sample type
Tissue sections -
Product overview
Giemsa Stain Kit (May-Grunwald) ab150670 is intended for use in the visualization of cells present in hematopoietic tissues and certain microorganisms. This kit may be used on formalin-fixed, paraffin-embedded or frozen sections.
Giemsa staining protocol summary:
- deparaffinize sections if necessary and rehydrate
- incubate with May-Grunwald solution for 5-7 min
- wash with PBS
- incubate with Giemsa solution for 10-15 min
- wash with PBS, and incubate in PBS for 5 min
- rinse with water and air dry
- clear with Xylene or similar, and mount
Other products for staining tissue sections
Find more kits and reagents in the special stains guide, or products for antigen retrieval, blocking, signal amplification, visualization, counterstaining, and mounting in the IHC kits and reagents guide.
-
Notes
Staining Interpretation
Nuclei Blue/Violet Cytoplasm Light Blue Collagen Pale Pink Muscle Fibre Pale Pink Erythrocytes Gray, Yellow or Pink Rickettsia Reddish-Purple Helicobacter Pylori Blue Mast Cells Dark Blue with Red Granules Control Tissue: Blood Film. Any well fixed tissue.
Properties
-
Storage instructions
Store at room temperature. Please refer to protocols. -
Components 100 tests Giemsa Stock Solution 1 x 500ml May Grunwald Stock Solution 1 x 500ml Phosphate Buffer solution (pH6.8) 1 x 500ml -
Research areas
Images
-
ab150670 Giemsa Stain Kit staining formalin-fixed-paraffin embedded human bone marror.
-
ab150670 (Giemsa stain) staining mast cells (deep pink) in formalin fixed paraffin embedded normal human colon.
*Tissue obtained from the Human Research Tissue Bank, supported by the NIHR Cambridge Biomedical Research Centre.
-
Staining using ab150670 - Giemsa Stain Kit (May-Grunwald).
Datasheets and documents
-
SDS download
-
Datasheet download
References (10)
ab150670 has been referenced in 10 publications.
- Huang L & Dai G Long non-coding RNA DCST1-AS1/hsa-miR-582-5p/HMGB1 axis regulates colorectal cancer progression. Bioengineered 13:12-26 (2022). PubMed: 34967274
- Qin D et al. LINC01207 promotes prostate cancer progression by sponging miR-1182 to upregulate AKT3. Oncol Lett 23:57 (2022). PubMed: 34992689
- Li C et al. Upregulation of exosomal circPLK1 promotes the development of non-small cell lung cancer through the miR-1294/ high mobility group protein A1 axis. Bioengineered 13:4185-4200 (2022). PubMed: 35114891
- Yu C et al. LINC00893 inhibits the progression of prostate cancer through miR-3173-5p/SOCS3/JAK2/STAT3 pathway. Cancer Cell Int 22:228 (2022). PubMed: 35818076
- Wu C et al. Long non-coding RNA DDX11-AS1 promotes esophageal carcinoma cell proliferation and migration through regulating the miR-514b-3p/RBX1 axis. Bioengineered 12:3772-3786 (2021). PubMed: 34281459
- Zeng W et al. Circular RNA hsa_circ_0033144 (CircBCL11B) regulates oral squamous cell carcinoma progression via the miR-579/LASP1 axis. Bioengineered 12:4111-4122 (2021). PubMed: 34288804
- Wu X et al. Fibroblast growth factor 11 (FGF11) promotes non-small cell lung cancer (NSCLC) progression by regulating hypoxia signaling pathway. J Transl Med 19:353 (2021). PubMed: 34404435
- Yen JH et al. Activation of dynamin-related protein 1 - dependent mitochondria fragmentation and suppression of osteosarcoma by cryptotanshinone. J Exp Clin Cancer Res 38:42 (2019). PubMed: 30691497
- Li H et al. miR-23b promotes cutaneous wound healing through inhibition of the inflammatory responses by targeting ASK1. Acta Biochim Biophys Sin (Shanghai) 50:1104-1113 (2018). PubMed: 30188966
- Wu YX et al. CD146+ skeletal stem cells from growth plate exhibit specific chondrogenic differentiation capacity in vitro. Mol Med Rep 16:8019-8028 (2017). PubMed: 28983600